Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Jun Chikumi"'
Autor:
Daiken Osaku, Tetsuro Oishi, Naoshi Kawamura, Yuki Iida, Hiroaki Komatsu, Akiko Kudoh, Jun Chikumi, Shinya Sato, Tasuku Harada
Publikováno v:
Reproductive Medicine and Biology, Vol 20, Iss 4, Pp 467-476 (2021)
Abstract Purpose To investigate the role of estrogen receptors (ERs) in high‐grade serous carcinoma (HGSC) and clear cell carcinoma (CCC) of the ovary and evaluate ERs as prognostic biomarkers for ovarian cancer. Methods This study included 79 pati
Externí odkaz:
https://doaj.org/article/2674ec40355046a8a4718b6faabd9568
Autor:
Michiko Nonaka, Seiya Sato, Daiken Osaku, Mayumi Sawada, Akiko Kudoh, Jun Chikumi, Shinya Sato, Tetsuro Oishi, Tasuku Harada
Publikováno v:
Gynecologic Oncology Reports, Vol 26, Iss , Pp 21-23 (2018)
Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a r
Externí odkaz:
https://doaj.org/article/6f41bc7b795b420d95b66287694e4c12
Autor:
Yuki Iida, Shinya Sato, Masayo Okawa, Kohei Hikino, Hiroaki Komatsu, Akiko Kudoh, Jun Chikumi, Tetsuro Oishi, Tasuku Harada, Fuminori Taniguchi
Publikováno v:
Acta Cytologica. 67:17-26
Introduction: We previously reported that preoperative human papillomavirus (HPV) type 16/18 positivity and postoperative high-risk (HR)-HPV test positivity are associated with abnormal postoperative cytology. In this study, we further examined wheth
Autor:
Yusuke Endo, Jun Chikumi, Eri Sato, Ai Ikebuchi, Hiroshi Sunada, Hisashi Noma, Marie Hamaguchi, Mitsuto Fukushige, Mayu Yamamoto, Yohei Tokita, Tasuku Harada, Fuminori Taniguchi
Publikováno v:
Medicine: Case Reports & Study Protocols; Jan2024, Vol. 5 Issue 1, p1-6, 6p
Autor:
Tetsuro Oishi, Akiko Kudoh, Tasuku Harada, Hiroaki Komatsu, Daiken Osaku, Jun Chikumi, Shinya Sato, Ruri Shimogai
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 46:2108-2114
Objective This study aimed to determine whether radical hysterectomy (RH) affects renal function. Methods Renal function was followed up in 83 patients with stage IB1-IIB cervical cancer who underwent RH during 2006-2015. Serum creatinine (sCre) leve
Autor:
Mayumi Sawada, Tasuku Harada, Tetsuro Oishi, Masayo Okawa, Jun Chikumi, Hiroaki Komatsu, Ruri Shimogai, Akiko Kudoh, Shinya Sato, Daiken Osaku
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Incidence of endometrial cancer has shown a remarkable increase globally. • Case of an obese patient who underwent panniculectomy combined surgical staging. • Combination of panniculectomy was effective for surgery in obese patient
Autor:
Hiroaki Komatsu, Masayo Okawa, Kohei Hikino, Yuki Iida, Daiken Osaku, Akiko Kudoh, Jun Chikumi, Shinya Sato, Tetsuro Oishi, Tasuku Harada
Publikováno v:
The journal of obstetrics and gynaecology researchReferences. 48(3)
We devised a simplified nerve-sparing radical hysterectomy that is simpler than commonly used procedures.We retrospectively examined 16 cases of classical non-nerve-sparing radical hysterectomy (non-nerve-sparing group) and 16 cases of simplified ner
Autor:
Tetsuro Oishi, Tasuku Harada, Hiroaki Komatsu, Jun Chikumi, Ruri Shimogai, Yuki Iida, S Sato, Daiken Osaku
Publikováno v:
Poster.
Objectives We aimed to analyze whether radiological and pathological lymph node status affected the prognosis in patients with epithelial ovarian cancer who underwent neoadjuvant chemotherapy (NAC) followed by interval debulking surgery (IDS). Method
Autor:
Jun Chikumi, Shinya Sato, Tetsuro Oishi, Tasuku Harada, Ruri Shimogai, Daiken Osaku, Yuki Iida, Hiroaki Komatsu
Publikováno v:
The journal of obstetrics and gynaecology researchReferences. 47(1)
AIM To analyze whether radiological and pathological lymph node statuses affected prognosis in patients with epithelial ovarian cancer who underwent neoadjuvant chemotherapy followed by interval debulking surgery. METHODS In total, 82 patients underg
Autor:
Shinya Sato, Mayumi Sawada, Tasuku Harada, Akiko Kudoh, Daiken Osaku, Tetsuro Oishi, Jun Chikumi, Seiya Sato, Michiko Nonaka
Publikováno v:
Gynecologic Oncology Reports, Vol 26, Iss, Pp 21-23 (2018)
Gynecologic Oncology Reports
Gynecologic Oncology Reports
Bevacizumab (Bev) is an antiangiogenic drug used to treat various malignances, including ovarian cancer (OC). Bev is generally well-tolerated; however, it has a characteristic toxicity profile. In particular, gastrointestinal perforation (GIP) is a r